-
1
-
-
0025942542
-
Assessment issues and the cost of schizophrenia
-
Andreasen N.C. Assessment issues and the cost of schizophrenia. Schizophrenia Bulletin 1991, 17(3):475-481.
-
(1991)
Schizophrenia Bulletin
, vol.17
, Issue.3
, pp. 475-481
-
-
Andreasen, N.C.1
-
2
-
-
0032526166
-
Extending the simple linear regression model to account for correlated responses: an introduction to generalized estimating equations and multi-level mixed modelling
-
Burton P., Gurrin L., Sly P. Extending the simple linear regression model to account for correlated responses: an introduction to generalized estimating equations and multi-level mixed modelling. Statistics in Medicine 1998, 17:1261-1291.
-
(1998)
Statistics in Medicine
, vol.17
, pp. 1261-1291
-
-
Burton, P.1
Gurrin, L.2
Sly, P.3
-
3
-
-
77956475205
-
Comparative effectiveness of long-acting risperidone in New Zealand: a report of resource utilization and costs in a 12-month mirror-image analysis
-
Carswell C., Wheeler A., Vanderpyl J., Robinson E. Comparative effectiveness of long-acting risperidone in New Zealand: a report of resource utilization and costs in a 12-month mirror-image analysis. Clinical Drug Investigation 2010, 30(11):777-787.
-
(2010)
Clinical Drug Investigation
, vol.30
, Issue.11
, pp. 777-787
-
-
Carswell, C.1
Wheeler, A.2
Vanderpyl, J.3
Robinson, E.4
-
4
-
-
0031916292
-
Compliance with medication regimens for mental and physical disorders
-
Cramer J., Rosenheck R. Compliance with medication regimens for mental and physical disorders. Psychiatric Services 1998, 49(2):196-201.
-
(1998)
Psychiatric Services
, vol.49
, Issue.2
, pp. 196-201
-
-
Cramer, J.1
Rosenheck, R.2
-
5
-
-
60349125075
-
Long-acting injectable risperidone and hospital readmission: a mirror-image study using a national claim-based database in Taiwan
-
Chang H.C., Tang C.H., Tsai S.J., Yen F.C., Su K.P. Long-acting injectable risperidone and hospital readmission: a mirror-image study using a national claim-based database in Taiwan. The Journal of Clinical Psychiatry 2009, 70(1):141.
-
(2009)
The Journal of Clinical Psychiatry
, vol.70
, Issue.1
, pp. 141
-
-
Chang, H.C.1
Tang, C.H.2
Tsai, S.J.3
Yen, F.C.4
Su, K.P.5
-
6
-
-
9644257391
-
Comparative efficacy and safety of long-acting risperidone and risperidone oral tablets
-
Chue P., Eerdekens M., Augustyns I., Lachaux B., Molcan P., Eriksson L., David A.S. Comparative efficacy and safety of long-acting risperidone and risperidone oral tablets. European Neuropsychopharmacology 2005, 15:111-117.
-
(2005)
European Neuropsychopharmacology
, vol.15
, pp. 111-117
-
-
Chue, P.1
Eerdekens, M.2
Augustyns, I.3
Lachaux, B.4
Molcan, P.5
Eriksson, L.6
David, A.S.7
-
7
-
-
0037012134
-
A comparison of risperidone and haloperidol for the prevention of relapse in patients with schizophrenia
-
Csernansky J.G., Mahmoud R., Brenner R. A comparison of risperidone and haloperidol for the prevention of relapse in patients with schizophrenia. New England Journal of Medicine 2002, 346:16-22.
-
(2002)
New England Journal of Medicine
, vol.346
, pp. 16-22
-
-
Csernansky, J.G.1
Mahmoud, R.2
Brenner, R.3
-
8
-
-
0015170072
-
The contribution of fluphenazine enanthate and decanoate in the prevention of readmission of schizophrenic patients
-
Denham J., Adamson L. The contribution of fluphenazine enanthate and decanoate in the prevention of readmission of schizophrenic patients. Acta Psychiatrica Scandinavica 1971, 47(4):420-430.
-
(1971)
Acta Psychiatrica Scandinavica
, vol.47
, Issue.4
, pp. 420-430
-
-
Denham, J.1
Adamson, L.2
-
9
-
-
0003597030
-
-
Oxford University Press, Oxford, United Kingdom
-
Diggle P.J., Liang K.Y., Zeger S.L. Analysis of longitudinal data 1994, Oxford University Press, Oxford, United Kingdom.
-
(1994)
Analysis of longitudinal data
-
-
Diggle, P.J.1
Liang, K.Y.2
Zeger, S.L.3
-
10
-
-
0344429683
-
Treatment of schizophrenia with long-acting injectable risperidone: a 12-month open-label trial of the first long-acting second-generation antipsychotic
-
Fleischhacker W.W., Eerdekens M., Karcher K., Remington G., Llorca P.M., Chrzanowski W., Gefvert O. Treatment of schizophrenia with long-acting injectable risperidone: a 12-month open-label trial of the first long-acting second-generation antipsychotic. The Journal of Clinical Psychiatry 2003, 64:1250-1257.
-
(2003)
The Journal of Clinical Psychiatry
, vol.64
, pp. 1250-1257
-
-
Fleischhacker, W.W.1
Eerdekens, M.2
Karcher, K.3
Remington, G.4
Llorca, P.M.5
Chrzanowski, W.6
Gefvert, O.7
-
11
-
-
0035154103
-
Clinical outcome following neuroleptic discontinuation in patients with remitted recent-onset schizophrenia
-
Gitlin M., Nuechterlein K., Subotnik K.L., Ventura J., Mintz J., Fogelson D.L., Bartzokis G., Aravagiri M. Clinical outcome following neuroleptic discontinuation in patients with remitted recent-onset schizophrenia. American Journal of Psychiatry 2001, 158:1835-1842.
-
(2001)
American Journal of Psychiatry
, vol.158
, pp. 1835-1842
-
-
Gitlin, M.1
Nuechterlein, K.2
Subotnik, K.L.3
Ventura, J.4
Mintz, J.5
Fogelson, D.L.6
Bartzokis, G.7
Aravagiri, M.8
-
12
-
-
0030761817
-
Pharmacoeconomic evaluation of antipsychotic therapy for schizophrenia
-
Glazer W., Johnstone B.M. Pharmacoeconomic evaluation of antipsychotic therapy for schizophrenia. The Journal of Clinical Psychiatry 1997, 58(suppl. 10):50-54.
-
(1997)
The Journal of Clinical Psychiatry
, vol.58
, Issue.SUPPL. 10
, pp. 50-54
-
-
Glazer, W.1
Johnstone, B.M.2
-
13
-
-
33644829405
-
Pharmacoeconomics of long-acting risperidone: results and validity of cost-effectiveness models
-
(Review)
-
Haycox A. Pharmacoeconomics of long-acting risperidone: results and validity of cost-effectiveness models. Pharmacoeconomics 2005, 23(Suppl 1):3-16. (Review).
-
(2005)
Pharmacoeconomics
, vol.23
, Issue.SUPPL 1
, pp. 3-16
-
-
Haycox, A.1
-
14
-
-
0034352084
-
Schizophrenia costs and treatment cost-effectiveness
-
Knapp M. Schizophrenia costs and treatment cost-effectiveness. Acta Psychiatrica Scandinavica 2000, 102:S15-S18.
-
(2000)
Acta Psychiatrica Scandinavica
, vol.102
-
-
Knapp, M.1
-
15
-
-
84858734196
-
Long acting risperidone in Australian patients with chronic schizophrenia: 24-month data from the e-STAR database
-
Lambert T., Emmerson B., Hustig H., Resseler S., Jacobs A., Butcher B. Long acting risperidone in Australian patients with chronic schizophrenia: 24-month data from the e-STAR database. BMC Psychiatry 2012, 12(1):25.
-
(2012)
BMC Psychiatry
, vol.12
, Issue.1
, pp. 25
-
-
Lambert, T.1
Emmerson, B.2
Hustig, H.3
Resseler, S.4
Jacobs, A.5
Butcher, B.6
-
16
-
-
73449130028
-
Effectiveness of a psychosocial intervention for relapse prevention in patients with schizophrenia receiving risperidone via long-acting injection
-
Lee S.H., Choi T.K., Suh S., Kim Y.W. Effectiveness of a psychosocial intervention for relapse prevention in patients with schizophrenia receiving risperidone via long-acting injection. Psychiatry Research 2010, 175(3):195-199.
-
(2010)
Psychiatry Research
, vol.175
, Issue.3
, pp. 195-199
-
-
Lee, S.H.1
Choi, T.K.2
Suh, S.3
Kim, Y.W.4
-
17
-
-
0042978712
-
Relapse prevention in schizophrenia with new-generation antipsychotics: a systematic review and exploratory meta-analysis of randomized, controlled trials
-
Leucht S., Barnes T.R., Kissling W., Engel R.R., Correll C., Kane J.M. Relapse prevention in schizophrenia with new-generation antipsychotics: a systematic review and exploratory meta-analysis of randomized, controlled trials. American Journal of Psychiatry 2003, 160:1209-1222.
-
(2003)
American Journal of Psychiatry
, vol.160
, pp. 1209-1222
-
-
Leucht, S.1
Barnes, T.R.2
Kissling, W.3
Engel, R.R.4
Correll, C.5
Kane, J.M.6
-
18
-
-
77649173768
-
Longitudinal data analysis using generalized linear models
-
Liang K.Y., Zeger S. Longitudinal data analysis using generalized linear models. Biometrika 1986, 73(1):13-22.
-
(1986)
Biometrika
, vol.73
, Issue.1
, pp. 13-22
-
-
Liang, K.Y.1
Zeger, S.2
-
19
-
-
25144456112
-
Effectiveness of antipsychotic drugs in patients with chronic schizophrenia
-
Lieberman J.A., Stroup T.S., McEvoy J.P., Swartz M.S., Rosenheck R.A., Perkins D.O., Hsiao J.K. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. New England Journal of Medicine 2005, 353(12):1209-1223.
-
(2005)
New England Journal of Medicine
, vol.353
, Issue.12
, pp. 1209-1223
-
-
Lieberman, J.A.1
Stroup, T.S.2
McEvoy, J.P.3
Swartz, M.S.4
Rosenheck, R.A.5
Perkins, D.O.6
Hsiao, J.K.7
-
21
-
-
84888297396
-
-
National Institute for Clinical Excellence. Guidance on the use of newer (atypical) antipsychotic drugs for the prevention of relapse in patients with schizophrenia [online].Retrieved from:.
-
National Institute for Clinical Excellence., 2011. Guidance on the use of newer (atypical) antipsychotic drugs for the prevention of relapse in patients with schizophrenia [online].Retrieved from:. http://guidance.nice.org.uk/TA43.
-
(2011)
-
-
-
22
-
-
34250005736
-
Thirty-five months experience of risperidone long-acting injection in a UK psychiatric service including a mirror-image analysis of in-patient care
-
Niaz O.S., Haddad P.M. Thirty-five months experience of risperidone long-acting injection in a UK psychiatric service including a mirror-image analysis of in-patient care. Acta Psychiatrica Scandinavica 2007, 116:36-46.
-
(2007)
Acta Psychiatrica Scandinavica
, vol.116
, pp. 36-46
-
-
Niaz, O.S.1
Haddad, P.M.2
-
23
-
-
0017069599
-
Fluphenazine decanoate maintenance in schizophrenia: a retrospective study
-
Polonowita A., James N.M. Fluphenazine decanoate maintenance in schizophrenia: a retrospective study. The New Zealand Medical Journal 1976, 83:316-318.
-
(1976)
The New Zealand Medical Journal
, vol.83
, pp. 316-318
-
-
Polonowita, A.1
James, N.M.2
-
24
-
-
0346753734
-
Relapse and rehospitalization: Comparing oral and depot antipsychotics
-
Schooler N. Relapse and rehospitalization: Comparing oral and depot antipsychotics. The Journal of Clinical Psychiatry 2003, 64(Suppl 16):14-17.
-
(2003)
The Journal of Clinical Psychiatry
, vol.64
, Issue.SUPPL 16
, pp. 14-17
-
-
Schooler, N.1
-
25
-
-
67649939217
-
Risperidone long-acting injection: a 6-year mirror-image study of healthcare resource use
-
Taylor D., Fischetti C., Sparshatt A., Thomas A., Bishara D., Cornelius V. Risperidone long-acting injection: a 6-year mirror-image study of healthcare resource use. Acta Psychiatrica Scandinavica 2009, 120(2):97-101.
-
(2009)
Acta Psychiatrica Scandinavica
, vol.120
, Issue.2
, pp. 97-101
-
-
Taylor, D.1
Fischetti, C.2
Sparshatt, A.3
Thomas, A.4
Bishara, D.5
Cornelius, V.6
-
26
-
-
72149124211
-
Cost-Effectiveness of Long-Acting Risperidone Injection versus Alternative Atypical Antipsychotic Agents in Patients with Schizophrenia in China
-
Yang L., Li M., Tao L.B., Zhang M., Nicholl M.D., Dong P. Cost-Effectiveness of Long-Acting Risperidone Injection versus Alternative Atypical Antipsychotic Agents in Patients with Schizophrenia in China. Value in health 2009, 12(s3):66-69.
-
(2009)
Value in health
, vol.12
, Issue.3 S
, pp. 66-69
-
-
Yang, L.1
Li, M.2
Tao, L.B.3
Zhang, M.4
Nicholl, M.D.5
Dong, P.6
|